South Korea Medical Device Registration

Unlock the South Korean market with expert regulatory guidance, KGMP compliance support, and an independent local regulatory representative, with Cisema.

We help foreign manufacturers of medical devices, IVDs, and digital medical products navigate the full MFDS registration process, comply with Korean regulatory requirements, and maintain regulatory and quality compliance throughout the entire product lifecycle. As your experienced local regulatory partner, we support your market entry into Korea from initial strategy and device classification through approval and post-market surveillance.

With an experienced local team in South Korea and deep knowledge of the Korean “Medical Device Act,” “IVD Act,” and “Digital Medical Products Act,” Cisema acts as your independent Korean regulatory representative and compliance partner. We provide comprehensive support for MFDS approvals, KGMP conformity assessment, technical documentation, regulatory planning, Korean labeling, UDI compliance, and ongoing lifecycle management.

South Korea is widely recognized as one of the most advanced healthcare and technology markets in Asia, combining sophisticated healthcare infrastructure, strong purchasing power, rapid adoption of innovative technologies, and increasing demand for digital healthcare solutions. Korea has become an especially important market for AI-based medical devices, Software as a Medical Device (SaMD), Digital Therapeutics (DTx), wearable healthcare technologies, advanced IVD solutions, and aesthetic medical devices.

As Korean regulations continue to evolve rapidly, regulatory authorities are placing increasing emphasis on cybersecurity, software lifecycle management, AI governance, post-market surveillance, and quality system compliance. Having an effective MFDS regulatory strategy and strong local regulatory support has therefore become increasingly important for successful market entry and long-term commercial success.

From regulatory pathway assessment and dossier preparation to KGMP coordination, clinical and performance evaluation support, and post-market compliance, Cisema helps simplify your path to market entry in South Korea while giving you long-term flexibility, transparency, and control.

South Korea Medical Device Registration Services

We guide you through every step of medical device registration in Korea. We take care of compliance with MFDS requirements, advising you on the optimal market entry pathway, test methods and helping you through the whole process to achieving your medical device registration certificate. 

Regulatory Strategy & Classification

Determine the appropriate Korean medical device or IVD classification under the MFDS four-class risk-based system
Conduct product classification and risk-level assessment
Assess the most suitable Korean registration pathway, including notification, certification, approval, innovative device, and fast-track routes

Technical Documentation & Localization Support

Prepare and review Korean-style STED technical documentation in accordance with MFDS requirements
Draft and localize Korean labels, IFUs, and UDI information
Support software validation, cybersecurity documentation, and Korean regulatory compliance review

Testing, KGMP & Technical Support

Coordinate import and domestic transportation of test samples within South Korea
Supervise testing at MFDS-designated laboratories, including electrical safety, EMC, biocompatibility, and performance testing
Support KGMP conformity assessment activities and clinical/performance evaluation strategies

Registration Application & Submission

Create and manage MFDS online business accounts and application submissions
Prepare and submit Class I notifications, Class II certifications and approvals, and Class III & IV approval applications
Manage MFDS communications and supplementary responses

Post-Approval & Lifecycle Support

Ongoing regulatory compliance throughout the product lifecycle
Regulatory document management and maintenance
Strategic advice and support on license renewal, reclassification, post-approval deficiency letters, change applications and renewals

Local Authorized Representative Services for Korea

All foreign manufacturers of medical devices, IVDs, and digital medical products entering the South Korean market without a physical office in South Korea must appoint a local authorized representative, known as the Korean License Holder (KLH), as their in country representative. The KLH must be a legal entity residing in South Korea and acts as the legal license holder and regulatory liaison before the Ministry of Food and Drug Safety (MFDS) throughout the entire product lifecycle.

For overseas manufacturers, the KLH is not simply a filing agent. The KLH plays a central role in controlling and maintaining access to the Korean market and is responsible for managing submissions to the MFDS.

While appointing a distributor as KLH may initially appear commercially convenient, it can also create long-term limitations regarding distribution flexibility, certificate control, and intellectual property protection. Many manufacturers therefore prefer working with an independent regulatory partner to maintain greater commercial flexibility and long-term control of registrations.

The KLH compiles the STED and other application files in Korean and submits the completed dossier through the MFDS electronic submission portal.

At Cisema, we act as an independent Korean License Holder (KLH), providing manufacturers with transparent regulatory support while allowing full flexibility in selecting or changing distributors as business needs evolve.

Korea Legal Representation

Acting as local authorized representative and Korea License Holder (KLH)
MFDS communication and regulatory liaison
Regulatory representation before Korean authorities
Management of importer obligations

Regulatory Coordination

Ongoing regulatory updates
Inspection coordination
Customs and import support

Regulatory Compliance

Regulatory document management and maintenance
Korean labeling support, e-IFU and UDI support
KGMP coordination support

Post-Market Vigilance

Handle adverse event reporting and regulatory notifications
Coordinate Field Safety Corrective Actions (FSCAs), recalls, and corrective submissions
Support full conformity with South Korean market safety requirements

Conformity Assessment Bodies Collaboration

Provide documentation for audits by a registered CAB
Assist with conformity assessment requirements tied to device classification and risk

Regulatory Strategy

Guide your implementation of a Korea-compliant quality management system
Advise on rollout strategies and expansion across Asia Pacific

Global Communication

Provide multilingual support in English, Mandarin, German, and more
Align with your commercial, regulatory, and quality teams across time zones.

Why Work with Cisema?

One Partner, Full Lifecycle Support

From pre-market strategy to post-market compliance, we provide support to internal regulatory teams and ensure seamless lifecycle management.

Regional Reach, Global Presence

Based in Asia and Europe with a global team delivering global reach.

Cross-Industry Expertise

Pharma, biotech, medical devices, cosmetics, supplements, veterinary, industrial and consumer goods.

Proven Results

Over 20 years of regulatory submissions, regulatory expertise, and approvals to drive business success.

Role of a China Agent

Discover Our Other Medical Device Consulting Services in Southeast Asia

Malaysia

Singapore

Vietnam

Taiwan

Indonesia

The Philippines

Thailand

China

Hong Kong

Latest Insights

View More

Malaysia MDA Fully Adopts Electronic Establishment Licenses in 2026

MDA will issue only electronic establishment licenses, affecting medical device manufacturers, importers, and distributors.

June 11, 2026
Malaysia MDA Fully Adopts Electronic Establishment Licenses in 2026
stock photograph of a patient and healthcare professional in a modern Malaysian hospital cardiology department

MDA Join WHO Collaborative Registration Procedure (CRP) to Accelerate Approval of Prequalified IVDs

New WHO CRP pathway enables faster MDA review of eligible WHO-prequalified IVDs.

June 11, 2026
MDA Join WHO Collaborative Registration Procedure (CRP) to Accelerate Approval of Prequalified IVDs
Malaysian adult using a home in vitro diagnostic (IVD) test kit at a dining table in a modern middle-class Malaysian apartment

Malaysia MDA Publishes First Edition Guidance on Change Management for Registered Medical Devices

New MDA guidance introduces a risk-based framework for managing post-registration medical device changes, including software updates and SaMD.

June 11, 2026
Malaysia MDA Publishes First Edition Guidance on Change Management for Registered Medical Devices
stock photo of an advanced handheld vein visualization device being used by a Malaysian nurse in a modern private hospital treatment room in Malaysia

Malaysia and Thailand Fully Implement Medical Device Regulatory Reliance Program

The full implementation of the reliance program creates new opportunities for manufacturers to accelerate regional market entry by strategically leveraging approvals across both jurisdictions.

July 2, 2026
Malaysia and Thailand Fully Implement Medical Device Regulatory Reliance Program
unbranded portable ultrasound system being prepared for use by a Southeast Asian healthcare professional in a bright, modern outpatient healthcare setting

Malaysia Advances Digital Transformation of Healthcare Product Labeling

Malaysia’s latest regulatory updates expand electronic labelling for pharmaceuticals and simplify medical device label requirements for foreign manufacturers.

June 10, 2026
Malaysia Advances Digital Transformation of Healthcare Product Labeling
An over-the-shoulder close-up shot shows a healthcare worker or pharmacist holding a white medicine box in one hand and scanning its QR code with a black handheld barcode scanner in the other.

Malaysia MDA Updates Medical Device Definitions, Special Access, & Legacy Device Rules 

Malaysia’s MDA has issued major updates affecting medical device classification, special access exemptions, and management of obsolete and discontinued devices under the Medical Device Act 2012

May 27, 2026
Malaysia MDA Updates Medical Device Definitions, Special Access, & Legacy Device Rules 
Ultra-photorealistic stock photo of a modern patient monitoring device in active clinical use inside a contemporary Malaysian hospital room.
Previous
Previous

Get in Touch with Our Medical Devices Team

And discover how we can support you in achieving approval for your medical device or IVD in South Korea.

Request Proposal